Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+8.73%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$40.6B
AUM Growth
+$1.8B
(+4.6%)
Cap. Flow
-$667M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
14.98%
Holding
3,307
New
654
Increased
625
Reduced
659
Closed
844
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$477M |
| 2 |
Walmart
WMT
|
+$432M |
| 3 |
Microsoft
MSFT
|
+$331M |
| 4 |
Amazon
AMZN
|
+$329M |
| 5 |
GE Aerospace
GE
|
+$300M |
Top Sells
| 1 |
lululemon athletica
LULU
|
+$276M |
| 2 |
Cigna
CI
|
+$274M |
| 3 |
Exxon Mobil
XOM
|
+$272M |
| 4 |
Bank of America
BAC
|
+$253M |
| 5 |
Qualcomm
QCOM
|
+$234M |
Sector Composition
| 1 | Healthcare | 19.67% |
| 2 | Technology | 16.71% |
| 3 | Consumer Discretionary | 16.19% |
| 4 | Financials | 11.48% |
| 5 | Industrials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEVA
2001
Aeva Technologies
AEVA
$873M
| $55.2K | ﹤0.01% |
9,284
| – | – |
|
|
BFX
2002
DELISTED
BowFlex Inc.
BFX
| $54.4K | ﹤0.01% |
+40,567
| New | +$54.4K |
|
|
NAGE
2003
Niagen Bioscience, Inc. Common Stock
NAGE
$790M
| $52.9K | ﹤0.01% |
34,600
-47,492
| -58% | -$72.7K |
|
2004
Focus Universal
FCUV
$19.9M
| $52.6K | ﹤0.01% |
+2,104
| New | +$52.6K |
|
|
WIMI
2005
WiMi Hologram Cloud
WIMI
$42.4M
| $52.4K | ﹤0.01% |
+4,855
| New | +$52.4K |
|
|
LEV
2006
DELISTED
The Lion Electric Company
LEV
| $51.7K | ﹤0.01% |
27,782
| – | – |
|
2007
AvePoint
AVPT
$3.36B
| $50.3K | ﹤0.01% |
+12,217
| New | +$50.3K |
|
2008
DURECT Corp
DRRX
| $50.2K | ﹤0.01% |
+11,073
| New | +$50.2K |
|
2009
Itaú Unibanco
ITUB
$75.3B
| $49.2K | ﹤0.01% |
+11,110
| New | +$49.2K |
|
|
CURO
2010
DELISTED
CURO Group Holdings Corp.
CURO
| $48.8K | ﹤0.01% |
28,180
-14,994
| -35% | -$25.9K |
|
2011
Nuvation Bio
NUVB
$1.1B
| $48.3K | ﹤0.01% |
29,111
| – | – |
|
2012
Caesarstone
CSTE
$50.1M
| $48.1K | ﹤0.01% |
11,640
-50,820
| -81% | -$210K |
|
2013
MMTec
MTC
$23.5M
| $41.4K | ﹤0.01% |
+4,313
| New | +$41.4K |
|
|
SRTA
2014
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$349M
| $41K | ﹤0.01% |
+12,133
| New | +$41K |
|
|
GOEV
2015
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $39.4K | ﹤0.01% |
132
-20
| -13% | -$5.97K |
|
|
FRBK
2016
DELISTED
Republic First Bancorp Inc
FRBK
| $38.4K | ﹤0.01% |
28,254
-173,776
| -86% | -$236K |
|
2017
NextNav
NN
$2.28B
| $38K | ﹤0.01% |
+18,700
| New | +$38K |
|
2018
Nektar Therapeutics
NKTR
$899M
| $37.7K | ﹤0.01% |
+3,593
| New | +$37.7K |
|
2019
Ring Energy
REI
$217M
| $36.6K | ﹤0.01% |
19,241
-10,794
| -36% | -$20.5K |
|
2020
Cidara Therapeutics
CDTX
$1.65B
| $35.9K | ﹤0.01% |
+1,413
| New | +$35.9K |
|
2021
Alto Ingredients
ALTO
$91.3M
| $35.9K | ﹤0.01% |
+23,900
| New | +$35.9K |
|
2022
Travelers Companies
TRV
$62.9B
| $34.3K | ﹤0.01% |
200
-27,662
| -99% | -$4.74M |
|
2023
Korro Bio
KRRO
$294M
| $34K | ﹤0.01% |
+1,362
| New | +$34K |
|
2024
Aqua Metals
AQMS
$5.26M
| $32.7K | ﹤0.01% |
+163
| New | +$32.7K |
|
2025
Ocugen
OCGN
$331M
| $32.5K | ﹤0.01% |
+38,260
| New | +$32.5K |
|